This trial is testing a new drug to treat small cell lung cancer that has come back or spread. The goal is to see if it is safe and effective.
2 Primary · 2 Secondary · Reporting Duration: 12 month
Experimental Treatment
36 Total Participants · 3 Treatment Groups
Primary Treatment: AL8326 high dose group · No Placebo Group · Phase 2
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: